[Practical issues in the management of tuberculosis disease].

Rev Mal Respir

Responsable statistique, régime social des indépendants (RSI) Midi-Pyrénées, 31138 Balma cedex, France.

Published: March 2016

Introduction: Tuberculosis disease warrants standard therapeutic management as detailed in a guide published by the High Authority for Health (HAS) following the publication of the Public Health Law in 2004.

Methods: The medical services of the régime social des indépendants (RSI) carried out a national survey by targeting patients who, in 2011, were reimbursed for tuberculosis treatment or were admitted for long-term tuberculosis disease. Their physicians were contacted to detail the care pathway and treatment they had received.

Results: A total of 148 tuberculosis disease patients were enrolled, of whom 71.6% had respiratory localization of their disease. The diagnosis was made in healthcare institutions in 84.5% of cases. Standard treatment (phases 1 and 2) was used in 30.1% of cases. The recommended quadruple therapy was given in 55.2% of treatments in phase 1 and in accordance with the time recommended in 62.9% of cases. Phase 2 was the recommended two drugs combination therapy 80.4% of the time with the treatment duration respected in 51.0% of treatments. The difference from standard treatment was explained by the detection of health or social events in only 39.0% of cases.

Conclusion: This survey allows us to highlight a relative lack of knowledge of standard treatment as recommended by the HAS.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.rmr.2015.07.004DOI Listing

Publication Analysis

Top Keywords

tuberculosis disease
12
standard treatment
12
treatment
6
tuberculosis
5
[practical issues
4
issues management
4
management tuberculosis
4
tuberculosis disease]
4
disease] introduction
4
introduction tuberculosis
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!